This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
Ganguly will execute company's strategic focus on leveraging CustomGlycan to develop novel therapeutics
Expanding diagnostics footprint in East India
QIAGEN has started its cloud transformation journey with the firm belief that cloud computing can be a key enabler of future business growth
The innovative software module is designed to meet growing scientific demand from researchers and drug developers
The three-year collaboration will focus on the development of new tools for computational chemistry modelling as well as new molecular representations to advance the next generation of molecular machine learning
This new formulation represents a significant improvement over protease inhibitor-containing paediatric ARV formulations that have been used in South Africa for decades.
The production and supply in Canada are designed to address the growing need for no-carrier-added Lutetium-177 (n.c.a. Lu-177) in North America
Cantourage introduces second Clever Leaves medical cannabis product to the German market
New Director supports NASDAQ rule on diversity
Subscribe To Our Newsletter & Stay Updated
